CEL-SCI Warning Letter Shows Pitfalls Of Website Presentations Of Investigational Drugs
This article was originally published in The Pink Sheet Daily
Executive Summary
Website suggested that the unapproved cancer immunotherapy was safe and effective, FDA says.